These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 29140469)

  • 1. SuperDRUG2: a one stop resource for approved/marketed drugs.
    Siramshetty VB; Eckert OA; Gohlke BO; Goede A; Chen Q; Devarakonda P; Preissner S; Preissner R
    Nucleic Acids Res; 2018 Jan; 46(D1):D1137-D1143. PubMed ID: 29140469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WITHDRAWN--a resource for withdrawn and discontinued drugs.
    Siramshetty VB; Nickel J; Omieczynski C; Gohlke BO; Drwal MN; Preissner R
    Nucleic Acids Res; 2016 Jan; 44(D1):D1080-6. PubMed ID: 26553801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DrugCentral: online drug compendium.
    Ursu O; Holmes J; Knockel J; Bologa CG; Yang JJ; Mathias SL; Nelson SJ; Oprea TI
    Nucleic Acids Res; 2017 Jan; 45(D1):D932-D939. PubMed ID: 27789690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innovating by developing new uses of already-approved drugs: trends in the marketing approval of supplemental indications.
    DiMasi JA
    Clin Ther; 2013 Jun; 35(6):808-18. PubMed ID: 23726388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IntSide: a web server for the chemical and biological examination of drug side effects.
    Juan-Blanco T; Duran-Frigola M; Aloy P
    Bioinformatics; 2015 Feb; 31(4):612-3. PubMed ID: 25380960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SuperDrug: a conformational drug database.
    Goede A; Dunkel M; Mester N; Frommel C; Preissner R
    Bioinformatics; 2005 May; 21(9):1751-3. PubMed ID: 15691861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. e-PKGene: a knowledge-based research tool for analysing the impact of genetics on drug exposure.
    Hachad H; Overby CL; Argon S; Yeung CK; Ragueneau-Majlessi I; Levy RH
    Hum Genomics; 2011 Jul; 5(5):506-15. PubMed ID: 21807605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The drug-minded protein interaction database (DrumPID) for efficient target analysis and drug development.
    Kunz M; Liang C; Nilla S; Cecil A; Dandekar T
    Database (Oxford); 2016; 2016():. PubMed ID: 27055828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New drugs of 1998.
    Hussar DA
    J Am Pharm Assoc (Wash); 1999; 39(2):151-206; quiz 289-92. PubMed ID: 10079651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
    Meanwell NA
    Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DrugBank: a comprehensive resource for in silico drug discovery and exploration.
    Wishart DS; Knox C; Guo AC; Shrivastava S; Hassanali M; Stothard P; Chang Z; Woolsey J
    Nucleic Acids Res; 2006 Jan; 34(Database issue):D668-72. PubMed ID: 16381955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New drugs of 1999.
    Hussar DA
    J Am Pharm Assoc (Wash); 2000; 40(2):181-221; quiz 323-7. PubMed ID: 10730022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SuperTarget and Matador: resources for exploring drug-target relationships.
    Günther S; Kuhn M; Dunkel M; Campillos M; Senger C; Petsalaki E; Ahmed J; Urdiales EG; Gewiess A; Jensen LJ; Schneider R; Skoblo R; Russell RB; Bourne PE; Bork P; Preissner R
    Nucleic Acids Res; 2008 Jan; 36(Database issue):D919-22. PubMed ID: 17942422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying adverse drug reactions and drug-induced diseases using network-based drug mapping.
    Shoshi A; Ogultarhan V; Hoppe T; Kormeier B; Müller U; Hofestädt R
    J Bioinform Comput Biol; 2015 Feb; 13(1):1540007. PubMed ID: 25666653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the associations between drug side-effects and therapeutic indications.
    Wang F; Zhang P; Cao N; Hu J; Sorrentino R
    J Biomed Inform; 2014 Oct; 51():15-23. PubMed ID: 24727480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Database identifies FDA-approved drugs with potential to be repurposed for treatment of orphan diseases.
    Xu K; Coté TR
    Brief Bioinform; 2011 Jul; 12(4):341-5. PubMed ID: 21357612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and regulatory features of drugs not initially approved by the FDA.
    Wang B; Avorn J; Kesselheim AS
    Clin Pharmacol Ther; 2013 Dec; 94(6):670-7. PubMed ID: 23963252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IDAAPM: integrated database of ADMET and adverse effects of predictive modeling based on FDA approved drug data.
    Legehar A; Xhaard H; Ghemtio L
    J Cheminform; 2016; 8():33. PubMed ID: 27303447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GraphSAW: a web-based system for graphical analysis of drug interactions and side effects using pharmaceutical and molecular data.
    Shoshi A; Hoppe T; Kormeier B; Ogultarhan V; Hofestädt R
    BMC Med Inform Decis Mak; 2015 Feb; 15():15. PubMed ID: 25881043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.